Here are relevant reports on : landscape-design-software-market
-
CAR T-Cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), Region, Competitive Landscape - Global Forecast to 2031
The global CAR T-cell therapy market, valued at USD 5.98 billion in 2025, stood at USD 6.78 billion in 2026 and is projected to advance at a resilient CAGR of 14.9% from 2026 to 2031, culminating in a forecasted valuation of USD 13.56 billion by the end of the period. The global CAR T-cell therapy market is growing due to rapid technological advances alongside rising investments from large pharma and well-funded biotech's.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Polymerase Chain Reaction Market – Usage Pattern and Replacement Trends, End User Analysis, Pricing Analysis, Comparative Analysis, Competitive Landscape Comparative Analysis and End User Preference Study
Polymerase chain reaction (PCR) is one of the revolutionary life science technologies that has not only made tremendous impact on the scientific community, but also affected many aspects of diseases diagnosis and treatment. The overall market for Polymerase chain reaction (PCR) technology has observed steady growth due to the expansion in its application areas and increased accuracy and precision. Specific technology segments of the PCR market, such as dPCR (digital PCR) and qPCR (real-time PCR), are witnessing higher market growth owing to their benefits such as real-time process monitoring, low reagent consumption, automation of workflow, and greater reproducibility and precision.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
Biotechnology Up-Stream & Down-Stream Processing Technology Analysis-Competitive Landscape Market - 2019 By Types, Application & Geography Current Trends & Technologies
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Endoluminal Suturing Devices Market Size, Growth by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecasts to 2027
The global endoluminal suturing devices market in terms of revenue was estimated to be worth $78 million in 2022 and is poised to reach $139 million by 2027, growing at a CAGR of 12.0% from 2022 to 2027. The prominent players in this market are Apollo Endosurgery, Inc. (US), Johnson & Johnson (US), Medtronic Plc (Ireland), Cook Group Incorporated (US), USGI Medical (US), Ovesco Endoscopy AG (Germany), Endo Tools Therapeutics S.A. (Belgium), ErgoSuture (US), and Sutrue Ltd. (UK).
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Skin Health Foods Market by Indication (Skin Conditions, Anti-Aging, Anti-Allergy), Region (North America, Europe, Asia Pacific, Rest of the World), Regulatory Landscape, Pricing Analysis - Global Forecast to 2026
The global skin health foods market growth is primed to transition from $1,929.5 million in 2021 to $2,651.5 million by 2026, showcasing a strong CAGR of 6.6%. The growth of this market is mainly driven by the high incidence of allergic diseases, the growth in health awareness among consumers, increasing R&D and production capacity for functional food and beverage products, and the increasing consumption of nutrient-enriched foods to improve overall health.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
Polyaspartic Coatings Market by Type (100% Solids Polyaspartic, Hybrid Polyaspartic), Systems (Quartz, Metallic), End-use Industry (Building & Construction, Transportation, Industrial, Power Generation, Landscape), Region - Global Forecast to 2025
The market for polyaspartic coatings is expected to grow USD 388 million by 2025, at a CAGR of 3.4% during the forecast period. The leading players in the polyaspartic coatings market are The Sherwin-Williams Company (US), PPG Industries (US), BASF SE (Germany), AkzoNobel (Netherlands), Hempel (Denmark), Carboline (US), Rust-Oleum (US), Laticrete International (US), SIKA AG (Switzerland), Feiyang Protech (China), Indmar Coatings (US), Satyen Polymers (India), and VIP Coatings (Germany).
- Published: September 2020
- Price: $ 4950
- TOC Available:
-
Halal Empty Capsules Market by Type (Gelatin, Non-gelatin), Application (Pharmaceutical Industry, Nutraceutical Industry, Cosmetic Industry), Competitive Landscape, Region (North America, Europe, APAC, LATAM, Middle East & Africa) - Global Forecast to 2029
The global halal empty capsules market, valued at US$1.17 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 5.4% from 2024 to 2029, culminating in a forecasted valuation of US$1.55 billion by the end of the period. The major factors contributing to the growth of this market include increased adoption of halal-certified and clean label products in emerging and developed countries and the presence of key market players providing halal empty capsules. Furthermore, the launch of new halal-certified products in the market is likely to drive market adoption in the coming years.
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Asia Pacific Healthcare Market Outlook – [By Health Indicators (Life Expectancy, Mortality), Disease Burden (Epidemiology, Average Cost Of Therapy), Health System (Infrastructure, Expenditure), Regulatory Landscape] - Analysis & Forecast To 2020
The APAC region showcases diverse healthcare challenges across various countries. These range from improving healthcare access in developing countries of Vietnam to tackling rising diabetes, cancer, and cardiovascular diseases in well developed nations of Japan and Pacific countries. In addition, regions of China and India that lie in between developing and well developed countries are facing increase in diseases burden, problems of poverty, limited access to high quality treatment, and slow increase in disposable income. The APAC Healthcare Market Outlook examines the health indicators and healthcare system across India, China, Japan, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Australia, and New Zealand. The APAC Healthcare Market Outlook is segmented into five broad categories: health status, healthcare system assessment, healthcare regulatory landscape, medical devices infrastructure assessment, hospital chain assessment in top 10 hospitals.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Future Of Automotive Industry Covers Original Equipment Manufacturer (OEM) Landscape, Connected Vehicles, Autonomous Driving Technologies, Electric Vehicles (Evs), Innovations In Battery Technology, Powertrains and Shared Mobility - Global Forecast 2030
The automotive industry, encompassing PV, LCV, and MHCV, size is projected to grow from 88 million units in 2024 and is projected to hit 104 million units by 2030, at a CAGR of 2.4%. The top automobile OEMs in the market are Toyota Motors Corporation (Japan), Tesla (USA), Volkswagen AG (Germany), Ford (USA) , BYD (China), Hyundai Motor Corporation (South Korea) and so on. The other companies that support the automobile industry with technology development are ABB, Siemens, Nvidia, Waymo, Bosch and others. These companies adopted new product launches, acquisitions, partnerships, collaborations, and other key strategies to gain traction in the automotive market.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Breast Cancer Liquid Biopsy Market by Circulating Biomarkers, Region, End User, Investments, Market Dynamics, Platform Comparison (NGS, PCR), Competitive Landscape (Acquisition, Mergers, Collaboration, Competitive technology) & Geography
The global breast cancer liquid biopsy market is projected to grow at a CAGR of 23.1%. Factors such as increasing prevalence of breast cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancements to augment market revenues, rising emphasis on personalized medicine in clinical practice, and increased funding for liquid biopsy R&D are driving the growth of the breast cancer liquid biopsy market. The key players in the global breast cancer liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
